"SPL has developed its proprietary Dendrimer Enhanced Products platform (DEP) to improve the effectiveness and safety of drugs, especially cancer treatments." Read the full article in Stockhead.
You have selected a link that will redirect you to a site maintained by a third party who is solely responsible for its contents.
Starpharma provides this link as a service to website visitors. Starpharma is not responsible for the privacy policy of any third party websites. Read the privacy policy of every website you visit.
To proceed, click ‘continue’.